Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-05-000829
Filing Date
2005-12-13
Accepted
2005-12-13 10:43:58
Documents
2
Period of Report
2005-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o18962e6vk.htm 6-K 15237
2 GRAPHIC o18962o1896202.gif GRAPHIC 2229
  Complete submission text file 0001130319-05-000829.txt   19882
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 051259991
SIC: 2834 Pharmaceutical Preparations